Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug shortage
Pharma
Novo Nordisk's semaglutide shortage officially resolved in US
The FDA has officially declared an end to the supply squeeze on Novo Nordisk’s GLP-1 drug semaglutide for diabetes and obesity in the U.S.
Fraiser Kansteiner
Feb 21, 2025 11:08am
ImmunityBio, SII win FDA nod to help combat BCG shortage
Feb 19, 2025 9:01am
Fierce's forecasts for the next year in biopharma
Jan 17, 2025 8:45am
Novo asks FDA to restrict compounding of legacy GLP-1 Victoza
Jan 3, 2025 3:25pm
Lilly seeks to intervene in compounded tirzepatide lawsuit
Jan 2, 2025 4:16pm
Novo, Lilly poised to overcome GLP-1 supply constraints in 2025
Dec 30, 2024 8:00am
